AUTHOR=Hadhiah Kawther , Alhashim Ali , Al-Dandan Hassan A. , Alhassan Eman , Alqarni Abdulaziz M. , Memish Abdullah Adil A. , Alabdali Majed 

TITLE=Guillain–Barré syndrome post-SARS-CoV-2 vaccine: a systematic review and data analysis on its clinical, laboratory, electrophysiological, and radiological features

JOURNAL=Frontiers in Neurology

VOLUME=Volume 15 - 2024

YEAR=2024

URL=https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2024.1332364

DOI=10.3389/fneur.2024.1332364

ISSN=1664-2295

ABSTRACT=Guillain-Barré syndrome (GBS) is a rare disease that affects almost 0.8-1.9 cases per 100,000 people worldwide every year. This is the most prevalent cause of subacute flaccid paralyzing illness today. It is a sub-acute inflammatory demyelinating polyradiculoneuropathy the typical scenario involves ascending symmetrical flaccid paralysis, but in some circumstances, sensory, autonomic, and cranial neuropathy may also be involved. Several vaccines have been found to have complications since the previous century. Numerous case reports of GBS in the literature have been reported following COVID-19 vaccines in recent times.